Cyanokit (hydroxocobalamin)
- Region
- 🇪🇺 EU
- Active substance
- hydroxocobalamin
- Company
- SERB SA
- Status
- Authorised
- Therapeutic area
- Poisoning
- EU approval
- Fri 23 Nov 2007
- Application
- EMEA/H/C/000806
- ATC
- V03AB33
- Official record
- www.ema.europa.eu
Indication
Treatment of known or suspected cyanide poisoning. Cyanokit is to be administered together with appropriate decontamination and supportive measures.
Regulatory milestones
No milestones recorded in the last year.
Follow Cyanokit
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.